International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
Clinical guideline published by International Myeloma Foundation (IMF) on
The International Myeloma Foundation (IMF) is dedicated to improving the quality of life for myeloma patients through education, research, and advocacy. They provide resources and support for patients and healthcare professionals, aiming to enhance treatment outcomes and promote awareness of myeloma.